{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:35:14Z","timestamp":1767141314118,"version":"build-2238731810"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10620-015-3922-3","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T02:59:42Z","timestamp":1447729182000},"page":"937-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-5077","authenticated-orcid":false,"given":"Brian I.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"3922_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/gut.48.1.103","volume":"48","author":"M Sch\u00f6niger-Hekele","year":"2001","unstructured":"Sch\u00f6niger-Hekele M, M\u00fcller C, Kutilek M, Oesterreicher C, et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103\u2013109.","journal-title":"Gut"},{"key":"3922_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4254\/wjh.v7.i3.406","volume":"7","author":"A Kinoshita","year":"2015","unstructured":"Kinoshita A, Onoda H, Fushiya N, Koike K, et al. Staging systems for hepatocellular carcinoma: current status and future perspectives. World J Hepatol. 2015;7:406\u2013424.","journal-title":"World J Hepatol"},{"key":"3922_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12072-009-9157-7","volume":"4","author":"BI Carr","year":"2009","unstructured":"Carr BI, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int. 2009;4:396\u2013405.","journal-title":"Hepatol Int"},{"key":"3922_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s004320050189","volume":"124","author":"M Pirisi","year":"1998","unstructured":"Pirisi M, Avellini C, Fabris C, Scott C, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol. 1998;124:397\u2013400.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3922_CR5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10620-006-9541-2","volume":"52","author":"BI Carr","year":"2007","unstructured":"Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxyprothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci. 2007;52:776\u2013782.","journal-title":"Dig Dis Sci"},{"key":"3922_CR6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00535-006-1950-7","volume":"41","author":"S Hagiwara","year":"2006","unstructured":"Hagiwara S, Kudo M, Kawasaki T, Nagashima M, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol. 2006;41:1214\u20131219.","journal-title":"J Gastroenterol"},{"key":"3922_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jjco\/hyg096","volume":"33","author":"M Gotoh","year":"2003","unstructured":"Gotoh M, Nakatani T, Masuda T, Mizuguchi Y, et al. Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin. Jpn J Clin Oncol. 2003;33:522\u2013526.","journal-title":"Jpn J Clin Oncol"},{"key":"3922_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","volume":"91","author":"Y Koike","year":"2001","unstructured":"Koike Y, Shiratori Y, Sato S, Obi S, et al. Des-gamma-carboxyprothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer. 2001;91:561\u2013569.","journal-title":"Cancer"},{"key":"3922_CR9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","volume":"116","author":"BI Carr","year":"2010","unstructured":"Carr BI, Kondragunta V, Buch SC, Branch RA. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer. 2010;116:1305\u20131314.","journal-title":"Cancer"},{"key":"3922_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004836-199203000-00021","volume":"14","author":"CR Taylor","year":"1992","unstructured":"Taylor CR. Computed tomography in the evaluation of the portal venous system. J Clin Gastroenterol. 1992;14:167\u2013172.","journal-title":"J Clin Gastroenterol"},{"key":"3922_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","volume":"168","author":"ME Tublin","year":"1997","unstructured":"Tublin ME, Dodd GD 3rd. Baron RL Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997;168:719\u2013723.","journal-title":"AJR Am J Roentgenol"},{"key":"3922_CR12","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00330-008-0931-z","volume":"18","author":"S Rossi","year":"2008","unstructured":"Rossi S, Ghittoni G, Ravetta V, et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol. 2008;18:1749\u20131756.","journal-title":"Eur Radiol"},{"key":"3922_CR13","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/j.1349-7006.2008.00981.x","volume":"99","author":"ZC Zeng","year":"2008","unstructured":"Zeng ZC, Fan J, Tang ZY, Zhou J, et al. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Sci. 2008;99:2510\u20132517.","journal-title":"Cancer Sci"},{"key":"3922_CR14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3748\/wjg.v21.i1.246","volume":"21","author":"Y Yamamoto","year":"2015","unstructured":"Yamamoto Y, Ikoma H, Morimura R, Shoda K, et al. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2015;21:246\u2013253.","journal-title":"World J Gastroenterol"},{"key":"3922_CR15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.gassur.2005.12.011","volume":"10","author":"YP Treut Le","year":"2006","unstructured":"Le Treut YP, Hardwigsen J, Ananian P, Sa\u00efsse J, et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg. 2006;10:855\u2013862.","journal-title":"J Gastrointest Surg"},{"key":"3922_CR16","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/j.1349-7006.2008.00981.x","volume":"99","author":"ZC Zeng","year":"2008","unstructured":"Zeng ZC, Fan J, Tang ZY, Zhou J, et al. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Sci. 2008;99:2510\u20132517.","journal-title":"Cancer Sci"},{"key":"3922_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.hepres.2005.01.015","volume":"32","author":"JY Cheong","year":"2005","unstructured":"Cheong JY, Lee KM, Cho SW, Won JH, et al. Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res. 2005;32:127\u2013133.","journal-title":"Hepatol Res"},{"key":"3922_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1477-7819-11-92","volume":"11","author":"JM Kim","year":"2013","unstructured":"Kim JM, Kwon CH, Joh JW, Ko JS, et al. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol. 2013;11:92.","journal-title":"World J Surg Oncol"},{"key":"3922_CR19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00268-013-2290-4","volume":"38","author":"KS Chok","year":"2014","unstructured":"Chok KS, Cheung TT, Chan SC, Poon RT, et al. Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg. 2014;38:490\u2013496.","journal-title":"World J Surg"},{"key":"3922_CR20","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.3748\/wjg.v20.i45.17141","volume":"20","author":"JZ Ye","year":"2014","unstructured":"Ye JZ, Zhang YQ, Ye HH, Bai T, et al. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol. 2014;20:17141\u201317147.","journal-title":"World J Gastroenterol"},{"key":"3922_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","volume":"47","author":"LM Kulik","year":"2008","unstructured":"Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008;47:71\u201381.","journal-title":"Hepatology"},{"key":"3922_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000348325","volume":"84","author":"WY Lau","year":"2013","unstructured":"Lau WY, Sangro B, Chen PJ, Cheng SQ, et al. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. Oncology. 2013;84:311\u2013318.","journal-title":"Oncology"},{"key":"3922_CR23","doi-asserted-by":"crossref","unstructured":"Kokabi N, Camacho JC, Xing M, El-Rayes BF et al. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. Cancer. 2015. doi: 10.1002\/cncr.29275 .","DOI":"10.1002\/cncr.29275"},{"key":"3922_CR24","doi-asserted-by":"crossref","unstructured":"No authors. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751\u20135.","DOI":"10.1002\/hep.510280322"},{"key":"3922_CR25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.seminoncol.2014.03.006","volume":"41","author":"BI Carr","year":"2014","unstructured":"Carr BI, Guerra V, Giannini EG, Farinati F, et al. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype. Semin Oncol. 2014;41:252\u2013258.","journal-title":"Semin Oncol"},{"key":"3922_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.seminoncol.2014.04.001","volume":"41","author":"BI Carr","year":"2014","unstructured":"Carr BI, Lin CY, Lu SN. Platelet-related phenotypic patterns in hepatocellular carcinoma patients. Semin Oncol. 2014;41:415\u2013421.","journal-title":"Semin Oncol"},{"key":"3922_CR27","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.5301\/jbm.5000064","volume":"29","author":"BI Carr","year":"2014","unstructured":"Carr BI, Guerra V, Giannini EG, Farinati F, et al. Significance of platelet and AFP levels and liver function parameters for HCC size and survival. Int J Biol Markers. 2014;29:e215\u2013e223.","journal-title":"Int J Biol Markers"},{"key":"3922_CR28","doi-asserted-by":"crossref","first-page":"10944","DOI":"10.3748\/wjg.v20.i31.10944","volume":"20","author":"XS Xu","year":"2014","unstructured":"Xu XS, Wan Y, Song SD, Chen W, et al. Model based on \u03b3-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis. World J Gastroenterol. 2014;20:10944\u201310952.","journal-title":"World J Gastroenterol"}],"updated-by":[{"DOI":"10.1007\/s10620-016-4088-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000}}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3922-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3922-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T12:06:11Z","timestamp":1567339571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3922-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3922-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}